TD SYNNEX Slides as Investors Weigh BlueStar Deal and Recent Volatility

TD SYNNEX Corporation (SNX) is down 3.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be continued investor caution after TD SYNNEX agreed to acquire BlueStar, a deal announced last week without publicly disclosed financial terms. With no major fresh company announcement on October 15, the pullback also looks consistent with profit-taking and position adjustments after a choppy stretch following the company’s late-September earnings release.

Details:

TD SYNNEX announced on October 7 that it entered into a definitive agreement to acquire BlueStar, expanding into AIDC, RFID, point-of-sale, robotics, and security technologies, but the release did not include deal terms.

The company posted record fiscal third-quarter 2026 results on September 24, including revenue of $21.6 billion and non-GAAP EPS of $5.68, both above its outlook.

TD SYNNEX also guided for fiscal fourth-quarter 2026 revenue of $21.8 billion to $22.6 billion and non-GAAP EPS of $5.65 to $6.15, showing the business backdrop remains solid even as the stock has traded sharply around recent updates.

Recent price action has been volatile, with a steep drop on September 24, a rebound in early October, and another decline this week, which suggests sentiment and deal-related uncertainty may be amplifying the move.

Sources:

TD SYNNEX Investor Relations, TD SYNNEX Newsroom, ChartExchange

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$SNX Insider Trading Activity

$SNX insiders have traded $SNX stock on the open market 68 times in the past 6 months. Of those trades, 0 have been purchases and 68 have been sales.

Here’s a breakdown of recent trading of $SNX stock by insiders over the last 6 months:

DENNIS POLK (Chair, Hyve Solutions) has made 0 purchases and 24 sales selling 37,500 shares for an estimated $9,763,729.
RICHARD T HUME has made 0 purchases and 39 sales selling 25,000 shares for an estimated $6,244,739.
MERLINE SAINTIL sold 4,368 shares for an estimated $1,001,407
REYNA THOMPSON (President, North America) has made 0 purchases and 3 sales selling 2,196 shares for an estimated $490,732.
ANN F VEZINA sold 1,273 shares for an estimated $325,951

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$SNX Hedge Fund Activity

We have seen 390 institutional investors add shares of $SNX stock to their portfolio, and 258 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BRAVE WARRIOR ADVISORS, LLC removed 1,612,014 shares (-52.8%) from their portfolio in Q2 2026, for an estimated $430,955,822
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,353,873 shares (+inf%) to their portfolio in Q2 2026, for an estimated $361,944,407
PRICE T ROWE ASSOCIATES INC /MD/ added 1,166,765 shares (+423.2%) to their portfolio in Q2 2026, for an estimated $311,922,955
METROPOLIS CAPITAL LTD removed 918,344 shares (-71.7%) from their portfolio in Q2 2026, for an estimated $245,510,084
FMR LLC added 883,266 shares (+15.9%) to their portfolio in Q2 2026, for an estimated $236,132,332
DIMENSIONAL FUND ADVISORS LP removed 858,643 shares (-32.0%) from their portfolio in Q2 2026, for an estimated $229,549,619
JPMORGAN CHASE & CO added 854,715 shares (+inf%) to their portfolio in Q2 2026, for an estimated $228,499,508

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$SNX Price Targets

Multiple analysts have issued price targets for $SNX recently. We have seen 8 analysts offer price targets for $SNX in the last 6 months, with a median target of $307.5.

Here are some recent targets:

Guy Hardwick from Barclays set a target price of $278.0 on 07/02/2026
Vincent Colicchio from Barrington Research set a target price of $325.0 on 06/26/2026
Erik Woodring from Morgan Stanley set a target price of $374.0 on 06/26/2026
David Vogt from UBS set a target price of $352.0 on 06/26/2026
Michael Ng from Goldman Sachs set a target price of $300.0 on 06/12/2026
David Paige from RBC Capital set a target price of $315.0 on 06/10/2026
Joseph Cardoso from JP Morgan set a target price of $298.0 on 05/27/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.